BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 33289703)

  • 1. Atorvastatin improves motor function, anxiety and depression by NOX2-mediated autophagy and oxidative stress in MPTP-lesioned mice.
    Yan J; Huang J; Liu A; Wu J; Fan H; Shen M; Lai X; Ma H; Sun W; Yang J; Xu Y
    Aging (Albany NY); 2020 Dec; 13(1):831-845. PubMed ID: 33289703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tristetraprolin destabilizes NOX2 mRNA and protects dopaminergic neurons from oxidative damage in Parkinson's disease.
    Sun X; Zhang H; Xie L; Qian C; Ye Y; Mao H; Wang B; Zhang H; Zhang Y; He X; Zhang S
    FASEB J; 2020 Nov; 34(11):15047-15061. PubMed ID: 32954540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of autophagy-related gene 5 (
    Hu ZY; Chen B; Zhang JP; Ma YY
    J Biol Chem; 2017 Nov; 292(44):18062-18074. PubMed ID: 28928221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allicin ameliorates obesity comorbid depressive-like behaviors: involvement of the oxidative stress, mitochondrial function, autophagy, insulin resistance and NOX/Nrf2 imbalance in mice.
    Gao W; Wang W; Zhang J; Deng P; Hu J; Yang J; Deng Z
    Metab Brain Dis; 2019 Oct; 34(5):1267-1280. PubMed ID: 31201726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin Prevents Early Oxidative Events and Modulates Inflammatory Mediators in the Striatum Following Intranasal 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Administration in Rats.
    Marques NF; Castro AA; Mancini G; Rocha FL; Santos ARS; Prediger RD; De Bem AF; Tasca CI
    Neurotox Res; 2018 Apr; 33(3):549-559. PubMed ID: 29164519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic mild stress augments MPTP induced neurotoxicity in a murine model of Parkinson's disease.
    Janakiraman U; Manivasagam T; Justin Thenmozhi A; Dhanalakshmi C; Essa MM; Song BJ; Guillemin GJ
    Physiol Behav; 2017 May; 173():132-143. PubMed ID: 28185878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7,8-dihydroxyflavone Ameliorates Motor Deficits Via Suppressing α-synuclein Expression and Oxidative Stress in the MPTP-induced Mouse Model of Parkinson's Disease.
    Li XH; Dai CF; Chen L; Zhou WT; Han HL; Dong ZF
    CNS Neurosci Ther; 2016 Jul; 22(7):617-24. PubMed ID: 27079181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.
    Jiang L; Wu X; Wang S; Chen SH; Zhou H; Wilson B; Jin CY; Lu RB; Xie K; Wang Q; Hong JS
    J Neuroinflammation; 2016 May; 13(1):110. PubMed ID: 27184631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy.
    Zhu J; Dou S; Jiang Y; Chen J; Wang C; Cheng B
    Brain Res; 2019 Jul; 1715():203-212. PubMed ID: 30914252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
    Zhang W; Wang T; Qin L; Gao HM; Wilson B; Ali SF; Zhang W; Hong JS; Liu B
    FASEB J; 2004 Mar; 18(3):589-91. PubMed ID: 14734632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism.
    Duan W; Zhu X; Ladenheim B; Yu QS; Guo Z; Oyler J; Cutler RG; Cadet JL; Greig NH; Mattson MP
    Ann Neurol; 2002 Nov; 52(5):597-606. PubMed ID: 12402257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apelin-36 mediates neuroprotective effects by regulating oxidative stress, autophagy and apoptosis in MPTP-induced Parkinson's disease model mice.
    Zhu J; Gao W; Shan X; Wang C; Wang H; Shao Z; Dou S; Jiang Y; Wang C; Cheng B
    Brain Res; 2020 Jan; 1726():146493. PubMed ID: 31586624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice.
    Zaitone SA; Hammad LN; Farag NE
    Pharmacol Rep; 2013; 65(5):1213-26. PubMed ID: 24399717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
    Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
    Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of HMG CoA reductase inhibitors against running wheel activity induced fatigue, anxiety like behavior, oxidative stress and mitochondrial dysfunction in mice.
    Kumar A; Vashist A; Kumar P; Kalonia H; Mishra J
    Pharmacol Rep; 2012; 64(6):1326-36. PubMed ID: 23406743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA.
    Zhao TT; Kim KS; Shin KS; Park HJ; Kim HJ; Lee KE; Lee MK
    BMC Complement Altern Med; 2017 Sep; 17(1):449. PubMed ID: 28877690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic mild stress induced anxiety-like behaviors can Be attenuated by inhibition of NOX2-derived oxidative stress.
    Lv H; Zhu C; Wu R; Ni H; Lian J; Xu Y; Xia Y; Shi G; Li Z; Caldwell RB; Caldwell RW; Yao L; Chen Y
    J Psychiatr Res; 2019 Jul; 114():55-66. PubMed ID: 31039481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.
    Bazzu G; Calia G; Puggioni G; Spissu Y; Rocchitta G; Debetto P; Grigoletto J; Zusso M; Migheli R; Serra PA; Desole MS; Miele E
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):482-90. PubMed ID: 20522009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis.
    Ren ZL; Wang CD; Wang T; Ding H; Zhou M; Yang N; Liu YY; Chan P
    Acta Pharmacol Sin; 2019 Apr; 40(4):441-450. PubMed ID: 29991712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADPH oxidase 2 activity in Parkinson's disease.
    Keeney MT; Hoffman EK; Farmer K; Bodle CR; Fazzari M; Zharikov A; Castro SL; Hu X; Mortimer A; Kofler JK; Cifuentes-Pagano E; Pagano PJ; Burton EA; Hastings TG; Greenamyre JT; Di Maio R
    Neurobiol Dis; 2022 Aug; 170():105754. PubMed ID: 35577065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.